8,779 reports of this reaction
1.8% of all DIPHENHYDRAMINE HYDROCHLORIDE reports
#11 most reported adverse reaction
RASH is the #11 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE, manufactured by Kenvue Brands LLC. There are 8,779 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE to RASH. This represents approximately 1.8% of all 482,745 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HYDROCHLORIDE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for DIPHENHYDRAMINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 8,779 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 1.8% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE, making it a notable side effect.
If you experience rash while taking DIPHENHYDRAMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.